Black Diamond Therapeutics, Inc. (BDTX)
3.00
+0.42
(+16.28%)
USD |
NASDAQ |
May 19, 16:00
2.94
-0.06
(-2.00%)
After-Hours: 20:00
Black Diamond Therapeutics EPS Diluted (Quarterly) : -0.1579 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Editas Medicine, Inc. | -0.2552 |
| IDEAYA Biosciences, Inc. | -1.111 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.036M |
| Total Expenses (Quarterly) | 9.036M |
| Enterprise Value | 71.53M |
| Earnings Yield | -25.26% |
| Normalized Earnings Yield | -22.26 |